PAREXEL INTERNATIONAL CORP

Delisted

CIK 799729fmd_0QKTP184FKMB114YAK085Z4BFDServices · Services-Commercial Physical & Biological ResearchTemplate: Standard

Coverage: Jul 01, 2008 to Jun 30, 2017, 33 periods

Income Statement · Annual · Millions · USD
Line item	FY2009	FY2010	FY2011	FY2012	FY2013	FY2014	FY2015	FY2016	FY2017
Total revenues	1,247	1,336	1,422	1,618	1,996	2,266	2,330	2,426	2,442
Gross profit	360	405	414	425	527	660	672	734	740
Research and development	21	21	23	21	24	27	24	19	18
Selling, general and administrative	216	246	259	263	319	380	367	385	401
Impairment of real estate	–	–	1	1	–	–	–	–	–
Operating income	76	83	82	89	136	199	200	224	191
Interest expense	24	15	17	7	7	9	7	9	12
Interest and investment income	–	–	–	5	4	–	–	–	–
Other non-operating income (expense)	(12)	(20)	(23)	(9)	(3)	(12)	0	(9)	(35)
Income before taxes	64	63	59	80	133	188	200	215	156
Income tax expense	25	22	10	17	37	59	52	60	49
Net income from continuing operations	39	42	49	63	96	129	148	155	107
Net income	39	42	49	63	96	129	148	155	107